Microbial Diagnostics for Cancer: A Step Forward but Not Prime Time Yet

Cynthia L Sears; Steven L Salzberg

doi:10.1016/j.ccell.2020.04.010

Microbial Diagnostics for Cancer: A Step Forward but Not Prime Time Yet

Cancer Cell. 2020 May 11;37(5):625-627. doi: 10.1016/j.ccell.2020.04.010.

Authors

Cynthia L Sears¹, Steven L Salzberg²

Affiliations

¹ Departments of Medicine and Oncology, Johns Hopkins University School of Medicine, Bloomberg-Kimmel Institute of Cancer Immunotherapy, Department of Molecular Microbiology & Immunology, Bloomberg School of Public Health, Baltimore, MD 21231, USA. Electronic address: csears@jhmi.edu.
² Departments of Biomedical Engineering, Computer Science, and Biostatistics, Johns Hopkins University, Baltimore, MD 21211, USA. Electronic address: salzberg@jhu.edu.

PMID: 32396856
DOI: 10.1016/j.ccell.2020.04.010

Abstract

Translational microbiome science in humans has not yet fully realized its clinical potentials. The analyses by Poore et al. in Nature offer a strong foundation on which to begin to build microbial diagnostics to detect cancer.

Microbial Diagnostics for Cancer: A Step Forward but Not Prime Time Yet

Authors

Affiliations

Abstract

Publication types

MeSH terms

Grants and funding